abstract |
The present invention relates to compounds of the formula where W, n, X and W ′ are defined above in the description of the invention; the invented compounds are modulators of the metabotropic glutamate receptor subtype 5 ("mGluR5"), useful in the treatment of diseases of the central nervous system regulated by mGluR5 receptors. |